Jefferies Financial Group Lowers Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $53.00
Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its price target lowered by Jefferies Financial Group from $70.00 to $53.00 in a research report report published on Tuesday,Benzinga reports. Jefferies Financial Group currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also commented on the stock. HC Wainwright reissued a […]
Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its price target lowered by Jefferies Financial Group from $70.00 to $53.00 in a research report report published on Tuesday,Benzinga reports. Jefferies Financial Group currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also commented on the stock. HC Wainwright reissued a […]
